Black Hawk Acquisition Corporation Units
NASDAQ Global MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Black Hawk Acquisition Corporation Units (BKHAU) is a blank check company, or special purpose acquisition company (SPAC), sponsored by Black Hawk Strategic Partners, focused on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company offers redeemable units consisting of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50; it targets sectors including energy transition, industrials, aerospace & defense, and select technology opportunities with an enterprise value between $300 million and $1 billion. Operations are primarily conducted in the United States, with headquarters in New York, New York; the SPAC was formed in 2024. Recent major developments include the December 2024 initial public offering, raising $230 million through 23 million units priced at $10 each, providing up to $207.8 million in trust (net of underwriting discounts) for pursuing an acquisition; the units began trading on Nasdaq under BKHAU on December 5, 2024, with separate trading of shares (BHKH) and warrants (BHKHW) expected 52 days post-IPO. No subsidiaries or parent company relationships are currently reported, and the company remains in the search phase for a suitable target with no specific partnerships, acquisitions, or product launches announced as of late 2025.
Vesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive Officer
Black Hawk Acquisition Corporation Amends Its Definitive Proxy Statement
Black Hawk Acquisition Corporation Amends Its Definitive Proxy Statement
Vesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter into a Business Combination Agreement to Create a Biotechnology Company Advancing p53-based Cancer Therapeutics Delivered Via Microvesicles
CORRECTION: Black Hawk Acquisition Corporation Welcomes Mr. Jonathan Ginsberg to Board
Black Hawk Acquisition Corporation Welcomes Mr. Jonathan Ginsberg to Board
U.S. IPO Weekly Recap: Tech IPOs Pop As End Of March Approaches
Black Hawk Acquisition Corporation Announces Closing of $69,000,000 Initial Public Offering
Black Hawk Acquisition Corporation Announces Pricing of $69,000,000 Upsized Initial Public Offering